IP Library › Granted Patent US 11,998,620
Granted Patent B2
US 11,998,620 · App. 18/456,931 · Granted Jun 4, 2024

PSMA targeted compounds and uses thereof

Inventors: James Basilion (Cleveland, OH); Zhenghong Lee (Cleveland, OH); Xinning Wang (Cleveland, OH)
Assignee: CASE WESTERN RESERVE UNIVERSITY
A61K51/0485C07B59/008A61K2121/00C07B2200/05
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,998,620
App. No.
18/456,931
Granted
Jun 4, 2024
Kind
B2
Abstract

PSMA targeted compounds, pharmaceutical compositions comprising these compounds, and methods for treating and detecting cancers in a subject are described herein.

Claims (2)

1. A compound having the formula of:

or a pharmaceutically acceptable salt thereof, chelated to a radionuclide selected from 225 Ac, 226 Ac, 227 Th, 211 Bi, 212 Bi, 213 Bi, 203 Pb, 212 Pb, or 177 Lu.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 25, 2024
From: BASILION, JAMES; LEE, ZHENGHONG; WANG, XINNING
To: CASE WESTERN RESERVE UNIVERSITY
Reel/Frame 067226/0911 →
Continuity (5)
Continuation In Part PCTUS2022079566 · Nov 9, 2022
Provisional Application 63359257 · Jul 8, 2022
Provisional Application 63348544 · Jun 3, 2022
Provisional Application 63277426 · Nov 9, 2021
Related Publication 20230414795A1 · Dec 28, 2023
Cited By (1)
US 12,514,939